Log off SitemapDisclaimer

Information on fentanyl drug residual and Matrifen®

On this page you will find information on fentanyl drug residual and the Matrifen® fentanyl patch from Nycomed as well as its use and efficiency.

Information on fentanyl drug residual and Matrifen® Get interesting information on fentanyl drug residual and the chronic pain patch Matrifen®.

>> Information on  fentanyl drug residual

The 72 hour transdermal fentanyl patch Matrifen provides a steady state concentration of fentanyl to ease pain in patients with severe chronic pain.

The fentanyl drug load is less than in other products, adding to a high degree of safety and low environmental burden.

About Nycomed
Nycomed is a pharmaceutical company dedicated to meeting needs in Europe. The company provides hospital products throughout the region and general practitioner and pharmacy medicines in selected markets.

New products are sourced through licensing agreements with research companies. Here Nycomed provides late-stage clinical development, registration and marketing. Nycomed employs about 3,500 people throughout Europe and Russia-CIS.

Special features

To access the site you must confirm being a healthcare professional - use the link on the left side of this page

Mode of action video

An animation presenting the Matrifen® patch;
- Application
- Mode of action

Additional material

- Product details
- Pharmacokinetics
- Technical profile
Conversion tables for download 

- Oral morphine to Matrifen (100:1)
- Oral morphine to Matrifen (150:1)
- Potency table